Showing results (1951-1960 of 1,985) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|December 15, 2023
Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension studyAngela Schulz, Nicola Specchio, Emily de Los Reyes, et al.
The Lancet. Neurology|February 16, 2024
Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trialCristina Tassorelli, Krisztián Nagy, Patricia Pozo-Rosich, et al.
The Lancet. Neurology|January 27, 2024
Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 studyRalf Reilmann, Karen E Anderson, Andrew Feigin, et al.
The Lancet. Neurology|May 20, 2024
Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trialGlenn Nielsen, Jon Stone, Teresa C Lee, et al.
The Lancet. Neurology|May 23, 2024
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichael Benatar, Thomas Hansen, Dror Rom, et al.
The Lancet. Neurology|November 17, 2023
Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort studyElianet Fonseca, Jose M Cabrera-Maqueda, Raquel Ruiz-García, et al.
The Lancet. Neurology|October 15, 2023
Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trialsRustam Al-Shahi Salman, Jacqueline Stephen, Jayne F Tierney, et al.
The Lancet. Neurology|September 22, 2023
Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialBettina C Henzi, Simone Schmidt, Sara Nagy, et al.
The Lancet. Neurology|September 22, 2023
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trialAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: global health considerationsJorge Correale, Andrew J Solomon, Jeffrey A Cohen, et al.
Pageof 199